tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Akash Tewari, 60 are a BUY (71.43%), 21 are a HOLD (25%), 3 are a SELL (3.57%).
Analyst Akash Tewari works at JEFFERIES with a stock forecast success ratio of 46.14% fulfilled within 141.91 days on average.
Akash Tewari’s has documented 160 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDGL, Madrigal Pharmaceuticals at 18-Jan-2024.
Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for ARVN (ARVINAS) at 6/21/2022. The price target of $42 was fulfilled within 2 days with a profit of $3.11 (8%) receiving and performance score of 39.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
35
$10.93 (45.41%)
34
4 days ago
13/16 (81.25%)
$11.15 (46.75%)
244
Buy
39
$14.93 (62.03%)
39
22 days ago
3/7 (42.86%)
$11.76 (43.17%)
101
Sell
25
$0.93 (3.86%)
31
2 months 3 days ago
2/2 (100%)
$-5.39 (-17.74%)
86
Hold
33
$8.93 (37.10%)
33
5 months 3 days ago
3/4 (75%)
$8.82 (36.48%)
32
Buy
35
$10.93 (45.41%)
37
5 months 28 days ago
17/33 (51.52%)
$10.3 (41.70%)
172
Which stock is Akash Tewari is most bullish on?
Which stock is Akash Tewari is most reserved on?
What Year was the first public recommendation made by Akash Tewari?
